Search Results - "Murray, Liam J"

QuPath: Open source software for digital pathology image analysis by Bankhead, Peter, Loughrey, Maurice B., Fernández, José A., Dombrowski, Yvonne, McArt, Darragh G., Dunne, Philip D., McQuaid, Stephen, Gray, Ronan T., Murray, Liam J., Coleman, Helen G., James, Jacqueline A., Salto-Tellez, Manuel, Hamilton, Peter W.

“…QuPath is new bioimage analysis software designed to meet the growing need for a user-friendly, extensible, open-source solution for digital pathology and…”
Get full text

Statin use after colorectal cancer diagnosis and survival: a population-based cohort study by Cardwell, Chris R, Hicks, Blanaid M, Hughes, Carmel, Murray, Liam J

“…To investigate whether statins used after colorectal cancer diagnosis reduce the risk of colorectal cancer-specific mortality in a cohort of patients with…”
Get full text

Statin use and survival from lung cancer: a population-based cohort study by Cardwell, Chris R, Mc Menamin, Úna, Hughes, Carmel M, Murray, Liam J

“…Preclinical evidence from lung cancer cell lines and animal models suggest that statins could have anticancer properties. We investigated whether statin users…”
Get full text

Statin use and survival in colorectal cancer: Results from a population-based cohort study and an updated systematic review and meta-analysis by Gray, Ronan T, Coleman, Helen G, Hughes, Carmel, Murray, Liam J, Cardwell, Chris R

“…Highlights • Statin use was associated with a generally weak improvement in survival. • The reduction in cancer-specific mortality was particularly…”
Get full text

Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study by Petrick, Jessica L, Falk, Roni T, Hyland, Paula L, Caron, Patrick, Pfeiffer, Ruth M, Wood, Shannon N, Dawsey, Sanford M, Abnet, Christian C, Taylor, Philip R, Guillemette, Chantal, Murray, Liam J, Anderson, Lesley A, Cook, Michael B

“…Esophageal adenocarcinoma (EA) is characterized by a strong male predominance. Sex steroid hormones have been hypothesized to underlie this sex disparity, but…”
Get full text

Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium by HOYO, Cathrine, COOK, Michael B, WU, Anna H, WARD, Mary H, CASSON, Alan G, MURRAY, Liam J, CORLEY, Douglas A, NYREN, Olof, PANDEYA, Nirmala, VAUGHAN, Thomas L, CHOW, Wong-Ho, GAMMON, Marilie D, KAMANGAR, Farin, FREEDMAN, Neal D, WHITEMAN, David C, BERNSTEIN, Leslie, BROWN, Linda M, RISCH, Harvey A, WEIMIN YE, SHARP, Linda

“…Previous studies suggest an association between obesity and oesophageal (OA) and oesophagogastric junction adenocarcinomas (OGJA). However, these studies have…”
Get full text

Beta-blocker usage and breast cancer survival: a nested case-control study within a UK Clinical Practice Research Datalink cohort by CARDWELL, Chris R, COLEMAN, Helen G, MURRAY, Liam J, ENTSCHLADEN, Frank, POWE, Des G

“…To investigate the association between post-diagnostic beta-blocker usage and risk of cancer-specific mortality in a large population-based cohort of female…”
Get full text

Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) by Cook, Michael B, Corley, Douglas A, Murray, Liam J, Liao, Linda M, Kamangar, Farin, Ye, Weimin, Gammon, Marilie D, Risch, Harvey A, Casson, Alan G, Freedman, Neal D, Chow, Wong-Ho, Wu, Anna H, Bernstein, Leslie, Nyrén, Olof, Pandeya, Nirmala, Whiteman, David C, Vaughan, Thomas L

“…Previous studies have evidenced an association between gastroesophageal reflux and esophageal adenocarcinoma (EA). It is unknown to what extent these…”
Get full text

Metformin use and survival after colorectal cancer: A population‐based cohort study by Mc Menamin, Úna C., Murray, Liam J., Hughes, Carmel M., Cardwell, Chris R.

“…Preclinical evidence suggests that metformin could delay cancer progression. Previous epidemiological studies however have been limited by small sample sizes…”
Get full text

Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study by Gray, Ronan T, Coleman, Helen G, Hughes, Carmel, Murray, Liam J, Cardwell, Chris R

“…Aspirin has been proposed as a novel adjuvant agent in colorectal cancer (CRC). Six observational studies have reported CRC-specific survival outcomes in…”
Get full text

PTGS2 (Cyclooxygenase-2) Expression and Survival among Colorectal Cancer Patients: A Systematic Review by KUNZMANN, Andrew T, MURRAY, Liam J, CARDWELL, Chris R, MCSHANE, Charlene M, MCMENAMIN, Una C, CANTWELL, Marie M

“…Studies have examined whether tumor expression of PTGS2 (also known as COX-2), an enzyme inhibited by nonsteroidal anti-inflammatory drugs such as aspirin, is…”
Get full text

Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review by Spence, Andrew D, Cardwell, Chris R, McMenamin, Úna C, Hicks, Blanaid M, Johnston, Brian T, Murray, Liam J, Coleman, Helen G

“…Gastric cancer (GC) has a poor prognosis with wide variation in survival rates across the world. Several studies have shown premalignant lesions gastric…”
Get full text

Statin use and breast cancer survival: a nationwide cohort study in Scotland by Mc Menamin, Úna C, Murray, Liam J, Hughes, Carmel M, Cardwell, Chris R

“…Preclinical evidence suggests that statins could delay cancer progression. Previous epidemiological findings have been inconsistent and some have been limited…”
Get full text

Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus by Bird–Lieberman, Elizabeth L, Dunn, Jason M, Coleman, Helen G, Lao–Sirieix, Pierre, Oukrif, Dahmane, Moore, Christina E, Varghese, Sibu, Johnston, Brian T, Arthur, Kenneth, McManus, Damian T, Novelli, Marco R, O'Donovan, Maria, Cardwell, Christopher R, Lovat, Laurence B, Murray, Liam J, Fitzgerald, Rebecca C

“…Background & Aims The risk of progression of Barrett's esophagus (BE) to esophageal adenocarcinoma (EAC) is low and difficult to calculate. Accurate tools to…”
Get full text

Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium by Thrift, Aaron P, Cook, Michael B, Vaughan, Thomas L, Anderson, Lesley A, Murray, Liam J, Whiteman, David C, Shaheen, Nicholas J, Corley, Douglas A

“…Results from studies examining the association between alcohol consumption and the risk of Barrett's esophagus have been inconsistent. We assessed the risk of…”
Get full text

Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk by Coleman, Helen G, Bhat, Shivaram K, Murray, Liam J, McManus, Damian T, O'Neill, Orla M, Gavin, Anna T, Johnston, Brian T

“…Risk stratification of Barrett's esophagus (BE) patients based on clinical and endoscopic features may help to optimize surveillance practice for esophageal…”
Get full text

Markers of Vitamin D Exposure and Esophageal Cancer Risk: A Systematic Review and Meta-analysis by Zgaga, Lina, O'Sullivan, Fiona, Cantwell, Marie M, Murray, Liam J, Thota, Prashanthi N, Coleman, Helen G

“…Vitamin D has been associated with reduced risk of many cancers, but evidence for esophageal cancer is mixed. To clarify the role of vitamin D, we performed a…”
Get full text

Intakes of dietary folate and other B vitamins are associated with risks of esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis by Sharp, Linda, Carsin, Anne-Elie, Cantwell, Marie M, Anderson, Lesley A, Murray, Liam J

“…Folate is implicated in carcinogenesis via effects on DNA synthesis, repair, and methylation. Efficient folate metabolism requires other B vitamins and is…”
Get more information

Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts by Cardwell, Chris R, Mc Menamin, Úna C, Hicks, Blánaid M, Hughes, Carmel, Cantwell, Marie M, Murray, Liam J

“…Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are commonly prescribed to the growing number of cancer patients…”
Get full text

Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study by Anderson, Lesley A, Watson, R G Peter, Murphy, Seamus J, Johnston, Brian T, Comber, Harry, Mc Guigan, Jim, Reynolds, John V, Murray, Liam J

“…To investigate risk factors associated with Barrett's oesophagus and oesophageal adenocarcinoma. This all-Ireland population-based case-control study recruited…”
Get full text